If you seriously think ABBV’s phase-3 investment of a few hundred million dollars in ABT-493/ABT-530 won’t generate an acceptable ROI, then I can’t help you insofar as it seems patently clear to me that it will, regardless of the competition and product pricing. (Even V-Pak is a highly profitable product for ABBV.)
Market Data 
Markets 
AI
